AgeX Therapeutics Inc.

AMEX: AGE · Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM

AgeX Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.33 -0.99 -1.96 -4.04
PEG Ratio
0.08 -0.03 -0.47 0.55
PS Ratio
1.46K 102.88 615.93 286.81
PB Ratio
127.43 2.67 -1.22 -3.49
P/FCF Ratio
-4.76 -1.87 -3.53 -5.26
P/OCF Ratio
-4.77 -1.87 -3.53 -5.26
OCF/S Ratio
-306.02 -54.93 -174.68 -54.55
Debt / Equity Ratio
0.42 0.80 -1.05 -1.12
Quick Ratio
2.40 0.13 0.24 0.25
Current Ratio
2.40 0.13 0.24 0.25
Asset Turnover
0.01 0.01 0.01 0.05
Interest Coverage
32.41 -2.03 -2.09 -7.33
Return on Equity
-17.38 -2.71 0.62 0.86
Return on Assets
-1.66 -1.24 -3.29 -3.24
Return on Invested Capital
-3.91 -1.02 -8.75 -7.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a -0.2 0.62 0.87
Net Profit Margin
-198.95 -104.25 -313.94 -70.97
Pretax Profit Margin
-198.95 -104.3 -309.47 -59.6
Operating Profit Margin
-304.43 -70.14 -205.15 -55.83
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-304.43 -69.22 -205.15 -55.09